Accountable Care Organization

ACO Public Reporting

ACO Name & Location
UHA ACO LLC
7979 Gateway Blvd.
Suite 120
Newark, CA 94560

ACO Primary Contact
Primary Contact Name:  Soumya Mamidala
Primary Contact Phone Number:  510-662-5811
Primary Contact Email Address:  SMamidala@stanfordhealthcare.org

ACO Participants
University HealthCare Alliance
ACO Participant in Joint Venture:  No

ACO Governing Body
Member Last Name	Member First Name	Member Title/ Position	Member (%) Voting Power	Membership Type	Legal Business Name/DBA
Krna	Catherine	Member, Interim Board Chair	30%	ACO Participant Representative	University Healthcare Alliance
Sankary	Richard	Member (MD)	30%	ACO Participant Representative	University Healthcare Alliance
Woods	George	Medicare Beneficiary (MD)	10%	Medicare Beneficiary	N/A
Kim	Michael	Interim Member	30%	ACO Participant Representative	University Healthcare Alliance

Key ACO Clinical and Administrative Leadership
David Overton	ACO Executive
Michael Kim, MD	Medical Director
Michael O’Connell	Compliance Officer
David Overton	Quality Assurance/Improvement Officer

Associated Committees and Committee Leadership
Committee Name	Committee Leader Name and Position
Quality Assurance and Utilization Management	Michael Kim, MD, Co-Chair David Overton, RN, Co-Chair
Finance and Cost Analysis	Michael Weatherford, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:
ACO Professionals in group practice arrangements

Shared Savings & Losses

Amount of Shared Savings/Losses

• First Agreement Period
  • Performance Year 2020 – $12,990,026.32
  • Performance Year 2019 – $1,918,033

Shared Savings Distribution

• First Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: 75%
    • Proportion invested in redesigned care processes/resources: 25%
    • Proportion of distribution to ACO participants: 0%
  • Performance Year 2019
    • Proportion invested in infrastructure: 50%
    • Proportion invested in redesigned care processes/resources: 50%
    • Proportion of distribution to ACO participants: 0%

Quality Performance Results

2020 Quality Performance Results

ACO #	Measure Name	Rate	ACO Mean
ACO-8	Risk Standardized, All Condition Readmission	14.11	15.07
ACO-38	Risk Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions	40.91	49.50
ACO-43	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	0.51	0.95
ACO-13	Falls: Screening for Future Fall Risk	83.09	84.97
ACO-14	Preventive Care and Screening: Influenza Immunization	90.68	76.03
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	94.74	81.67
ACO-18	Preventive Care and Screening: Screening for Depression and Follow-Up Plan	79.27	71.46
ACO-19	Colorectal Cancer Screening	77.10	72.59
ACO-20	Breast Cancer Screening	78.15	74.05
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	84.77	83.37
ACO-40	Depression Remission at Twelve Months	5.97	13.99
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	11.14	14.70
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	65.44	72.87

 

For previous years’ financial and quality performance results, please visit data.cms.gov.

Payment Rule Waivers

• Skilled Nursing Facility (SNF) 3-day Rule Waiver:
  • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.

---

Beneficiary Information Notice
Click here to print the Beneficiary Information Notice from your Primary Care Provider (PCP).

If you are a beneficiary and would like information about MSSP, please call:

• 1-800-MEDICARE (1-800-633-4227)
• Teletypewriter users, please call 1-877-486-2048